The Discounted Cash Flow (DCF) valuation of Crinetics Pharmaceuticals Inc (CRNX) is (14.45) USD. With the latest stock price at 53.66 USD, the upside of Crinetics Pharmaceuticals Inc based on DCF is -126.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.9% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (68.30) - (7.11) | (14.45) |
| Upside | -227.3% - -113.2% | -126.9% |